Dr. Gail Faith Schwartz, MD

Dr. Schwartz practices at Glaucoma Consultants in Baltimore, Maryland.

Dr. Schwartz's NPI, 1184619819, was assigned on September 19, 2005. Dr. Schwartz graduated from Perelman School of Med at the University of Pennsylvania in 1991. Dr. Schwartz holds Maryland license 00047525.

Dr. Schwartz's primary practice is Glaucoma Consultants, at 6565 N Charles St Suite 302 Suite 302, Baltimore, MD 21204-5804. The practice phone is (410) 825-9225.

Dr. Schwartz's primary practice is Glaucoma Consultants in Baltimore, Maryland. Dr. Schwartz is also affiliated with Greater Baltimore Medical Center. Dmand AI also links Dr. Schwartz to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Schwartz is licensed in Maryland.

CMS data shows 5,671 Medicare services from Dr. Schwartz across 23 procedure codes in 2024, for 1,215 Medicare patients. Medicare paid $459,456 for them.

CMS counts 1,215 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 75 to 84, with 511 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 73, with 58% women.

In 2024, Dr. Schwartz wrote 5,507 Medicare Part D claims for 1,019 patients. 67% of them were for generic drugs. CMS names the drug for 5,404 of them, across 29 drugs with 11 or more claims each, at $723,226 in total drug cost. In 2023, CMS named 4,581 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 133 procedures of cataract surgery by Dr. Schwartz, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Schwartz, published from 2008 to 2021. 2013 was the busiest year, with 5. The most frequent topics are Antihypertensive Agents, Ophthalmic Solutions and Cloprostenol. Dr. Schwartz has published most often in Curr Med Res Opin. Dr. Schwartz's most frequent co-authors are Vaishali Dinesh Patel, MD, Frank Cotter, MD and Yassine J. Daoud, MD.

CMS Open Payments shows 334 general payments to Dr. Schwartz from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Aerie Pharmaceuticals, Inc. paid the most, $62,159.

Dr. Schwartz graduated from Perelman School of Med at the University of Pennsylvania in 1991.